Pertussis Acellular Vaccine Adjuvanted With TQL1055
Condition:   Pertussis Interventions:   Other: TQL1055;   Biological: Acellular pertussis vaccine Sponsor:   Adjuvance Technologies, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 11, 2021 Category: Research Source Type: clinical trials

Trial to Evaluate the Safety, Tolerability, and Immunogenicity of A Hexavalent Group B Streptococcus Vaccine When Administered Concomitantly With Tdap in Healthy Nonpregnant Women
Condition:   Group B Streptococcus Infections Interventions:   Biological: Hexavalent Group B streptococcus vaccine;   Biological: Tetanus, diphtheria, and acellular pertussis vaccine;   Biological: Placebo Sponsor:   Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2021 Category: Research Source Type: clinical trials